Viewing Study NCT01667250


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2026-01-03 @ 9:28 PM
Study NCT ID: NCT01667250
Status: COMPLETED
Last Update Posted: 2018-06-20
First Post: 2012-08-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Non-Invasive Neurostimulation for the Prevention of Chronic Migraine
Sponsor: ElectroCore INC
Organization:

Study Overview

Official Title: Non-Invasive Neurostimulation of the Vagus Nerve With the GammaCore Device for the Prevention of Chronic Migraine
Status: COMPLETED
Status Verified Date: 2018-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this multi-center, prospective, double-blind, randomized, sham-controlled pilot study is to study feasibility and collect preliminary clinical data related to the safety and clinical benefits of daily use of non-invasive vagal nerve stimulation with the GammaCore device for the prevention of chronic migraine, and to support the development and approval of a larger pivotal study.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: